The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study

By Eby Elizabeth L.   Boye Kristina S.   Lage Maureen J.  

Journal of Medical Economics, Vol. 16, Iss. 10, 2013-10 ,pp. : 1231-1237

Informa Healthcare

Access to resources Recommend Favorite

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

By Xie Lin   Wei Wenhui   Pan Chunshen   Baser Onur  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite

Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products

By Bullano Michael F.   Al-Zakwani Ibrahim S.   Fisher Maxine D.   Menditto Laura   Willey Vincent J.  

Current Medical Research and Opinion, Vol. 21, Iss. 2, 2005-02 ,pp. : 291-298

Informa Healthcare

Access to resources Recommend Favorite

Comparing insulin vials to pens – comparison of charges, not healthcare benefits

By Thethi Tina K.  

Journal of Medical Economics, Vol. 16, Iss. 10, 2013-10 ,pp. : 1228-1230

Informa Healthcare

Access to resources Recommend Favorite

Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free‐mixed aspart and detemir insulin: an open labeled randomized trial

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 16, Iss. 5, 2015-08 ,pp. : 345-353

John Wiley & Sons Inc

Access to resources Recommend Favorite